Streptomycin 1gm Vial For Injection
Overview
What is this medicine?
How to Use This Medicine
For proper storage and disposal of this medication, consult with your doctor, nurse, or pharmacist if you need to keep it at home.
If you miss a dose, contact your doctor promptly to determine the best course of action.
Lifestyle & Tips
- Report any changes in hearing, ringing in the ears, dizziness, or problems with balance immediately.
- Report any decrease in urine output, swelling, or unusual tiredness.
- Report any muscle weakness or difficulty breathing.
- Stay well-hydrated unless otherwise instructed by your doctor.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Balance problems
Confusion
Dizziness or fainting
Headache
Muscle weakness
New or worsening trouble breathing
Abnormal burning, numbness, or tingling sensations
Twitching
Seizures
Upset stomach or vomiting
Ringing in the ears, hearing loss, or other changes in hearing
Feeling of fullness in the ears
Changes in eyesight
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Antibiotic-Associated Diarrhea
Diarrhea is a common side effect of antibiotics. In rare cases, a severe form of diarrhea called Clostridioides difficile-associated diarrhea (CDAD) may occur. This condition can lead to a life-threatening bowel problem. If you experience any of the following symptoms, contact your doctor immediately:
Stomach pain
Cramps
Very loose, watery, or bloody stools
Do not treat diarrhea without consulting your doctor first.
Other Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you are bothered by any of the following side effects or if they do not go away, contact your doctor:
Diarrhea
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Ringing in the ears (tinnitus)
- Hearing loss or difficulty hearing
- Dizziness or vertigo
- Unsteadiness or difficulty with balance
- Decreased urination
- Swelling in the ankles, feet, or hands
- Unusual muscle weakness
- Difficulty breathing
- Rash, itching, or hives
Before Using This Medicine
It is essential to inform your doctor about any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including any symptoms that occurred.
This medication may interact with other medications or exacerbate existing health conditions. To ensure safe use, disclose all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues to your doctor and pharmacist. Carefully review your medication list and health history to confirm that it is safe to take this medication in conjunction with your other medications and health conditions.
Do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor to avoid potential interactions or adverse effects.
Precautions & Cautions
If you are 65 years or older, exercise caution when using this drug, as you may be more susceptible to side effects. Women who are pregnant or become pregnant while taking this medication should be aware that it may harm the unborn baby. If you are pregnant or suspect you may be pregnant, notify your doctor immediately.
If you are breastfeeding, consult your doctor to discuss potential risks to your baby and determine the best course of action.
Overdose Information
Overdose Symptoms:
- Severe ototoxicity (hearing loss, vertigo)
- Severe nephrotoxicity (renal failure)
- Neuromuscular blockade (respiratory depression, paralysis)
- Hypotension
What to Do:
Seek immediate medical attention. Call 911 or Poison Control (1-800-222-1222). Treatment is supportive and may include hemodialysis to remove the drug, calcium salts to reverse neuromuscular blockade, and respiratory support.
Drug Interactions
Major Interactions
- Other nephrotoxic drugs (e.g., amphotericin B, cisplatin, cyclosporine, loop diuretics, NSAIDs, vancomycin): Increased risk of nephrotoxicity.
- Other ototoxic drugs (e.g., loop diuretics, cisplatin, vancomycin): Increased risk of ototoxicity.
- Neuromuscular blocking agents (e.g., succinylcholine, rocuronium, vecuronium): Potentiation of neuromuscular blockade, leading to respiratory depression/paralysis.
- Botulinum toxin: Increased risk of neuromuscular blockade.
Moderate Interactions
- Cephalosporins (some): May increase risk of nephrotoxicity.
- Oral anticoagulants (e.g., warfarin): May potentiate anticoagulant effect (rare, due to gut flora alteration).
- Digoxin: Reduced absorption of digoxin (theoretical, due to gut flora alteration).
Monitoring
Baseline Monitoring
Rationale: Streptomycin is primarily renally eliminated and is nephrotoxic. Baseline assessment is crucial for dosing and monitoring.
Timing: Prior to initiation of therapy.
Rationale: Streptomycin is ototoxic (vestibular and auditory). Baseline assessment helps identify pre-existing impairment and monitor for new onset.
Timing: Prior to initiation of therapy.
Rationale: Aminoglycosides can cause electrolyte disturbances.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: At least twice weekly, or more frequently in patients with impaired renal function or receiving concomitant nephrotoxic drugs.
Target: Maintain within normal limits or stable baseline.
Action Threshold: Increase in serum creatinine by >0.5 mg/dL or >50% from baseline, or significant decrease in urine output.
Frequency: Periodically during therapy, especially in patients on prolonged treatment or with risk factors for ototoxicity.
Target: No significant change from baseline.
Action Threshold: New onset or worsening of hearing loss or vestibular symptoms (e.g., vertigo, tinnitus).
Frequency: For certain indications (e.g., endocarditis) or in patients with renal impairment, obesity, or prolonged therapy. Trough levels before 3rd or 4th dose, peak levels 30-60 min after end of infusion (IV) or 1 hour after IM injection.
Target: Trough: <5 mcg/mL; Peak: 20-30 mcg/mL (for once-daily dosing, trough may be undetectable). Specific targets vary by indication and dosing regimen.
Action Threshold: Trough levels >5 mcg/mL (increased risk of toxicity); Peak levels outside therapeutic range (suboptimal efficacy or increased toxicity).
Frequency: Weekly or as clinically indicated.
Target: Within normal limits.
Action Threshold: Significant hypokalemia, hypomagnesemia, or hypocalcemia.
Symptom Monitoring
- Hearing loss (difficulty hearing, ringing in ears/tinnitus)
- Vertigo, dizziness, nystagmus, ataxia (vestibular toxicity)
- Decreased urine output, swelling (nephrotoxicity)
- Muscle weakness, difficulty breathing (neuromuscular blockade)
- Rash, fever, itching (hypersensitivity reactions)
Special Patient Groups
Pregnancy
Category D. Streptomycin crosses the placenta and has been associated with irreversible congenital deafness in infants whose mothers received the drug during pregnancy. Use only if the potential benefit justifies the potential risk to the fetus, especially in life-threatening situations where safer alternatives are not available (e.g., multi-drug resistant TB).
Trimester-Specific Risks:
Lactation
L3 (Moderately Safe). Streptomycin is excreted into breast milk in low concentrations. While oral absorption by the infant is poor, there is a theoretical risk of altering infant gut flora or direct toxicity. Monitor breastfed infants for diarrhea, candidiasis, or signs of ototoxicity/nephrotoxicity. Use with caution; consider alternative agents if possible.
Pediatric Use
Use with caution. Dosing must be carefully calculated based on weight and renal function. Children, especially infants, may be more susceptible to ototoxicity and nephrotoxicity. Close monitoring of renal function and auditory function is essential.
Geriatric Use
Elderly patients are at increased risk for ototoxicity and nephrotoxicity due to age-related decline in renal function and pre-existing hearing impairment. Dosing should be adjusted based on creatinine clearance, and close monitoring of renal function and auditory function is crucial. Lower doses or extended dosing intervals may be necessary.
Clinical Information
Clinical Pearls
- Streptomycin is a critical component of multi-drug regimens for tuberculosis, especially drug-resistant forms.
- Due to its significant toxicity (ototoxicity, nephrotoxicity), careful patient selection, dose adjustment based on renal function, and rigorous monitoring are essential.
- Peak and trough levels are often monitored to optimize efficacy and minimize toxicity, particularly in patients with renal impairment or on prolonged therapy.
- Patients should be counseled extensively on the signs and symptoms of ototoxicity and nephrotoxicity and instructed to report them immediately.
- Administer IM injections deep into a large muscle mass to minimize local irritation.
Alternative Therapies
- For tuberculosis: Isoniazid, Rifampin, Pyrazinamide, Ethambutol (first-line agents); Bedaquiline, Delamanid, Linezolid, Clofazimine, Cycloserine, p-Aminosalicylic acid (second-line/newer agents for MDR-TB).
- For bacterial endocarditis: Gentamicin (another aminoglycoside) is commonly used in combination with beta-lactams.